Day: October 2, 2025

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, is pleased to announce today that it has received two key final reports related to its potential breakthrough drug for Multiple Sclerosis: the 90-day oral toxicity study report and the toxicokinetic study report for Lucid-21-302 (“Lucid-MS”). These studies were commissioned to provide key data to support an Investigational New Drug (IND) application with the US FDA for a phase-2 clinical trial in Multiple Sclerosis. “We...

MONACO, Oct. 02, 2025 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE), an international owner and provider of containerships for charter, announced the election of two Class III directors at the Company’s virtual annual meeting of stockholders held today. The elected Class III directors are Konstantinos Konstantakopoulos and Charlotte Stratos who were elected to hold office for a term ending at the annual meeting of stockholders in 2028 and until their successors have been duly elected and qualified. Stockholders also ratified the appointment of Ernst & Young (Hellas) Certified Auditors Accountants S.A. as the Company’s independent auditors for the fiscal year ending December 31, 2025. About Costamare Inc. Costamare Inc. is one of the world’s leading owners and providers of containerships for charter. The Company...

MALVERN, Pa., Oct. 02, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that executive leadership will present at the 2025 Cell & Gene Meeting on the Mesa, Chardan’s 9th Annual Genetic Medicines Conference, and the 2025 Maxim Growth Summit. “These industry and investor meetings provide an excellent forum to share specifically how Ocugen is advancing toward our goal of three BLAs in the next three years,” said Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen. “We are excited to share our contribution toward bringing a new generation of gene therapies to market and engage with potential partners to join us on our journey.” At Meeting on the Mesa, Abhi Gupta, Executive Vice President, Commercial...

Milestone Highlights Continued Advisor and Investor Demand for Daily Income Strategy SEATTLE, Wash., Oct. 02, 2025 (GLOBE NEWSWIRE) — TappAlpha, a fintech-powered ETF issuer focused on making advanced investing strategies accessible, today announced that its flagship fund, the TappAlpha SPY Growth & Daily Income ETF (Nasdaq: TSPY), has surpassed $100 million in assets under management (AUM).Launched in August 2024, TSPY has gained rapid traction with both advisors and retail investors by offering a differentiated approach to income generation—blending core S&P 500 exposure with an actively managed daily (0DTE – zero days to expiration) covered call overlay. This structure seeks to deliver consistent, tax-efficient income while preserving participation in broad market growth. “This milestone reflects the trust...

WASHINGTON, Oct. 02, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the third quarter ended September 30, 2025 before the New York market opens on Thursday, October 23, 2025. A conference call will be held to discuss these financial results on Thursday, October 23, 2025, at 9:00 a.m. Eastern Time and will be hosted by senior management. The conference call will be simulcast live on the Internet and can be accessed by logging onto the Company’s investor relations website. A replay of the webcast will be available on the Company’s investor relations website for 90 days. About FTI ConsultingFTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 7,900 employees located in 32 countries and...

AUSTIN, TX and DURHAM, NC, Oct. 02, 2025 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-related diseases, today announced that Company management will participate in a panel discussion focused on key takeaways from the United European Gastroenterology Week (UEGW) Conference 2025. The session will be moderated by covering analysts Martin Fan, Ph.D. and David Nierengarten, Ph.D., and will feature KOL Marla Dubinsky, M.D., Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai Health System.  Conference DetailsFormat: Panel Discussion Session Title: Wedbush UEGW Conference 2025...

The Only* Active ETF Focused on Gold and Silver Miners Rapidly Gains Assets NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) — Sprott Asset Management USA, Inc. today announced that its Sprott Active Gold & Silver Miners ETF (Nasdaq: GBUG) (“GBUG”) reached $100 million in assets under management as of September 22, 2025. GBUG is an actively managed ETF that aims to provide long-term capital appreciation by investing in shares of gold- and silver-focused companies that are engaged in exploring, developing and mining; or royalty and streaming companies engaged in the financing of gold and silver assets. GBUG’s investment strategy is value-oriented and contrarian. “Gold and silver mining stocks have outperformed in recent months as prices of physical bullion surged,” said John Hathaway, CFA, Managing Partner, Sprott and Senior Portfolio...

ANAVEX3-71-002 trial achieved its primary endpoint demonstrating safety and tolerability in both male and female adults Oral ANAVEX®3-71 tablet exhibits superior pharmacokinetics compared to the current immediate-release oral capsule, enabling once-daily dosing NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced successful development of a once-daily oral tablet formulation for the ANAVEX®3-71 program. The once-daily modified-release oral tablet exhibits superior...

– Data from ATH434-201 double-blind Phase 2 trial to be featured in oral session and multiple poster presentations – MELBOURNE, Australia and SAN FRANCISCO, Oct. 02, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced  that data from the ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) will be featured at the 2025 International Congress of Parkinson’s Disease and Movement Disorders (MDS) taking place October 5-9, 2025 in Honolulu, HI, USA. “We look forward to presenting data from the Phase 2 double-blind clinical trial of ATH434 at MDS 2025 and educating leaders in the movement disorder community on its potential...

Nevada Tech Hub selects Dragonfly Energy for first-round funding, with contract finalization in progress Funding to support manufacturing upgrades that are expected to improve efficiency and reduce costs Project to expand Nevada’s skilled battery workforce through new training and hiring initiativesRENO, Nev., Oct. 02, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, announced today that Nevada Tech Hub, a program designed to strengthen Nevada’s lithium battery supply chain, has selected the Company for funding in its first round of awards. The contract is currently being finalized. Nevada Tech Hub is one of 31 Tech Hubs nationwide designated by the federal government as playing a key role in...